Expert Rev Endocrinol Metab. 2008;3(6):691-697. Elimination of sitagliptin occurs primarily via renal excretion (79%) and involves active tubular secretion. Sitagliptin is a substrate for human ...
The oral solution is supplied in a 120mL bottle containing 25mg of sitagliptin per mL. Brynovin ™, an oral solution formulation of sitagliptin, is now available from Azurity Pharmaceuticals. Brynovin ...
Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results